Literature DB >> 18618839

Role of multivesicular bodies and their components in the egress of enveloped RNA viruses.

A Calistri1, C Salata, C Parolin, G Palù.   

Abstract

As an enveloped virus buds, the nascent viral capsid becomes wrapped in a plasma membrane-derived lipid envelope, and a membrane fission event is thus necessary to separate the virion from the host cell. This membrane fission event is well characterised in the case of enveloped RNA viruses, where it is promoted by late assembly domains (L-domains) present at the level of specific viral structural proteins. Research conducted over the past 10 years has demonstrated that L-domains represent docking sites for cellular proteins essential for the biogenesis of a cellular organelle, the multivesicular body (MVB). In this way, enveloped RNA viruses hijack the MVB components to the cellular site where the budding is executed. This review will focus on the cellular machinery exploited by enveloped RNA viruses in order to be released from infected cells. The role of ubiquitin and lipids in viral budding will also be discussed.

Entities:  

Mesh:

Year:  2009        PMID: 18618839     DOI: 10.1002/rmv.588

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  30 in total

1.  Protein analysis of purified respiratory syncytial virus particles reveals an important role for heat shock protein 90 in virus particle assembly.

Authors:  Anuradha Radhakrishnan; Dawn Yeo; Gaie Brown; Myint Zu Myaing; Laxmi Ravi Iyer; Roland Fleck; Boon-Huan Tan; Jim Aitken; Duangmanee Sanmun; Kai Tang; Andy Yarwood; Jacob Brink; Richard J Sugrue
Journal:  Mol Cell Proteomics       Date:  2010-06-08       Impact factor: 5.911

2.  Cellular VPS4 is required for efficient entry and egress of budded virions of Autographa californica multiple nucleopolyhedrovirus.

Authors:  Zhaofei Li; Gary W Blissard
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 3.  Multivesicular bodies in neurons: distribution, protein content, and trafficking functions.

Authors:  Christopher S Von Bartheld; Amy L Altick
Journal:  Prog Neurobiol       Date:  2011-01-07       Impact factor: 11.685

4.  Human Cytomegalovirus UL135 and UL136 Genes Are Required for Postentry Tropism in Endothelial Cells.

Authors:  Farah Bughio; Mahadevaiah Umashankar; Jean Wilson; Felicia Goodrum
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

5.  ITCH E3 Ubiquitin Ligase Interacts with Ebola Virus VP40 To Regulate Budding.

Authors:  Ziying Han; Cari A Sagum; Mark T Bedford; Sachdev S Sidhu; Marius Sudol; Ronald N Harty
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

6.  Molecular cloning, expression and characterization of a novel vacuolar protein sorting 4 gene in silkworm, Bombyx mori.

Authors:  Hengchuan Xia; Chunxia Zhang; Fan Feng; Yi Yuan; Yang Zhou; Xiaoyong Liu; Keming Zhu; Qin Yao; Keping Chen
Journal:  Mol Biol Rep       Date:  2012-10-09       Impact factor: 2.316

7.  Tsg101 interacts with herpes simplex virus 1 VP1/2 and is a substrate of VP1/2 ubiquitin-specific protease domain activity.

Authors:  Martina Caduco; Alessandra Comin; Marta Toffoletto; Denis Munegato; Elena Sartori; Michele Celestino; Cristiano Salata; Cristina Parolin; Giorgio Palù; Arianna Calistri
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

8.  PIV5 M protein interaction with host protein angiomotin-like 1.

Authors:  Zifei Pei; Yuting Bai; Anthony P Schmitt
Journal:  Virology       Date:  2009-11-24       Impact factor: 3.616

9.  Ubiquitination of the Cytoplasmic Domain of Influenza A Virus M2 Protein Is Crucial for Production of Infectious Virus Particles.

Authors:  Wen-Chi Su; Wen-Ya Yu; Shih-Han Huang; Michael M C Lai
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

10.  Herpes simplex virus type 2 tegument protein UL56 relocalizes ubiquitin ligase Nedd4 and has a role in transport and/or release of virions.

Authors:  Yoko Ushijima; Fumi Goshima; Hiroshi Kimura; Yukihiro Nishiyama
Journal:  Virol J       Date:  2009-10-16       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.